Skip to main content

Advertisement

Table 4 Genes sorted by SVM weight, schizophrenia versus control

From: Combining gene expression, demographic and clinical data in modeling disease: a case study of bipolar disorder and schizophrenia

Expression data only Demographic, clinical, and expression data
All subjects All subjects
SVM-weight p-value q-value ID GenBank Symbol SVM-weight p-value q-value ID GenBank Symbol
-6.70E-02 1.13E-03 2.46E-01 201137_s_at NM_002121 HLA-DPB1 1.06E-01 1.39E-10 3.11E-06 Drug use   
5.99E-02 4.71E-02 1.00E+00 214877_at BE794663 CDKAL1 6.74E-02 2.88E-09 3.21E-05 Alcohol use   
-5.62E-02 1.19E-01 1.00E+00 218948_at AL136679 QRSL1 5.16E-02 4.71E-02 1.00E+00 214877_at BE794663 CDKAL1
-5.50E-02 5.31E-05 4.79E-02 203851_at NM_002178 IGFBP6 -5.07E-02 5.31E-05 4.30E-02 203851_at NM_002178 IGFBP6
-5.29E-02 6.22E-03 5.62E-01 204545_at NM_000287 PEX6 -5.05E-02 6.22E-03 5.51E-01 204545_at NM_000287 PEX6
5.21E-02 1.17E-01 1.00E+00 202944_at NM_000262 NAGA -4.84E-02 1.19E-01 1.00E+00 218948_at AL136679 QRSL1
-4.83E-02 7.19E-02 1.00E+00 201123_s_at NM_001970 EIF5A 4.60E-02 1.17E-01 1.00E+00 202944_at NM_000262 NAGA
4.79E-02 7.06E-02 1.00E+00 210075_at AF151074 2-Mar 4.57E-02 9.84E-02 1.00E+00 206785_s_at NM_002260 KLRC2/1
4.76E-02 7.70E-02 1.00E+00 204418_x_at NM_000848 GSTM2 -4.56E-02 1.13E-03 2.35E-01 201137_s_at NM_002121 HLA-DPB1
4.76E-02 6.82E-02 1.00E+00 204550_x_at NM_000561 GSTM1 -4.55E-02 5.69E-02 1.00E+00 218055_s_at NM_018268 WDR41
-4.64E-02 9.14E-02 1.00E+00 218051_s_at NM_022908 NT5DC2 4.51E-02 7.06E-02 1.00E+00 210075_at AF151074 2-Mar
-4.56E-02 6.35E-02 1.00E+00 218002_s_at NM_004887 CXCL14 -4.38E-02 5.28E-02 1.00E+00 219592_at NM_024596 MCPH1
4.52E-02 9.84E-02 1.00E+00 206785_s_at NM_002260 KLRC2/1 -4.31E-02 4.12E-02 1.00E+00 205145_s_at NM_002477 MYL5
-4.48E-02 9.45E-02 1.00E+00 204295_at NM_003172 SURF1 -4.23E-02 2.78E-02 1.00E+00 206108_s_at NM_006275 SFRS6
-4.47E-02 2.78E-02 1.00E+00 206108_s_at NM_006275 SFRS6 4.15E-02 6.82E-02 1.00E+00 204550_x_at NM_000561 GSTM1
4.45E-02 3.91E-03 4.65E-01 212854_x_at AB051480 NBPF10 4.14E-02 3.91E-03 4.54E-01 212854_x_at AB051480 NBPF10
-4.37E-02 5.28E-02 1.00E+00 219592_at NM_024596 MCPH1 -4.04E-02 6.35E-02 1.00E+00 218002_s_at NM_004887 CXCL14
4.34E-02 1.10E-01 1.00E+00 201141_at NM_002510 GPNMB -3.98E-02 7.19E-02 1.00E+00 201123_s_at NM_001970 EIF5A
4.32E-02 2.48E-02 1.00E+00 215823_x_at U64661 LOC341315 3.96E-02 7.62E-06 1.13E-02 Smoking at TOD   
4.28E-02 4.33E-02 1.00E+00 221752_at AL041728 SSH1 3.93E-02 2.48E-02 9.94E-01 215823_x_at U64661 LOC341315
Male subjects Male subjects
-5.90E-02 1.59E-04 4.87E-02 201137_s_at NM_002121 HLA-DPB1 7.25E-02 2.42E-10 5.40E-06 Drug use   
-5.81E-02 8.14E-02 9.87E-01 218948_at AL136679 QRSL1 6.57E-02 1.79E-09 1.33E-05 Alcohol use   
-5.36E-02 2.46E-02 6.09E-01 218055_s_at NM_018268 WDR41 -6.16E-02 3.87E-04 8.24E-02 HSV 1 OD Z-score   
4.73E-02 7.55E-03 3.68E-01 215009_s_at U92014 SEC31A -5.44E-02 2.46E-02 6.04E-01 218055_s_at NM_018268 WDR41
3.97E-02 7.06E-02 9.39E-01 209823_x_at M17955 HLA-DQB1 -4.98E-02 8.14E-02 9.84E-01 218948_at AL136679 QRSL1
3.97E-02 3.96E-03 2.69E-01 220313_at NM_022049 GPR88 4.71E-02 7.55E-03 3.64E-01 215009_s_at U92014 SEC31A
3.90E-02 2.96E-02 6.65E-01 204550_x_at NM_000561 GSTM1 -4.11E-02 1.59E-04 4.68E-02 201137_s_at NM_002121 HLA-DPB1
3.64E-02 6.72E-02 9.24E-01 214877_at BE794663 CDKAL1 4.03E-02 4.45E-04 8.62E-02 Smoking at TOD   
-3.63E-02 9.60E-05 3.77E-02 203851_at NM_002178 IGFBP6 3.97E-02 3.96E-03 2.64E-01 220313_at NM_022049 GPR88
-3.59E-02 8.41E-02 9.94E-01 221875_x_at AW514210 HLA-F 3.67E-02 5.43E-02 8.51E-01 203554_x_at NM_004219 PTTG1
3.58E-02 2.52E-02 6.15E-01 201141_at NM_002510 GPNMB -3.43E-02 8.71E-03 3.84E-01 204670_x_at NM_002125 HLA-DRB1
-3.58E-02 1.57E-02 4.94E-01 203031_s_at NM_000375 UROS -3.35E-02 8.41E-02 9.90E-01 221875_x_at AW514210 HLA-F
-3.56E-02 1.26E-02 4.60E-01 204295_at NM_003172 SURF1 -3.32E-02 1.57E-02 4.90E-01 203031_s_at NM_000375 UROS
3.56E-02 5.43E-02 8.55E-01 203554_x_at NM_004219 PTTG1 -3.31E-02 9.60E-05 3.58E-02 203851_at NM_002178 IGFBP6
3.55E-02 4.40E-02 7.84E-01 206339_at NM_004291 CARTPT 3.26E-02 4.40E-02 7.80E-01 206339_at NM_004291 CARTPT
-3.52E-02 9.35E-02 1.00E+00 208729_x_at D83043 HLA-B 3.25E-02 7.06E-02 9.36E-01 209823_x_at M17955 HLA-DQB1
-3.50E-02 8.71E-03 3.88E-01 204670_x_at NM_002125 HLA-DRB1 -3.24E-02 9.35E-02 1.00E+00 208729_x_at D83043 HLA-B
3.48E-02 6.76E-02 9.25E-01 221752_at AL041728 SSH1 3.21E-02 6.76E-02 9.21E-01 221752_at AL041728 SSH1
-3.46E-02 7.98E-02 9.82E-01 203374_s_at AW612376 TPP2 3.16E-02 6.18E-02 8.93E-01 204570_at NM_001864 COX7A1
3.38E-02 6.18E-02 8.97E-01 204570_at NM_001864 COX7A1 3.09E-02 2.96E-02 6.61E-01 204550_x_at NM_000561 GSTM1
Female subjects Female subjects
2.54E-02 1.85E-03 1.00E+00 219044_at NM_018271 THNSL2 3.49E-02 2.07E-02 1.00E+00 Left brain   
-2.18E-02 1.71E-02 1.00E+00 208691_at BC001188 TFRC 2.44E-02 1.85E-03 1.00E+00 219044_at NM_018271 THNSL2
-2.12E-02 2.36E-01 1.00E+00 202747_s_at NM_004867 ITM2A -2.08E-02 1.71E-02 1.00E+00 208691_at BC001188 TFRC
-2.04E-02 1.75E-01 1.00E+00 200606_at NM_004415 DSP 2.07E-02 5.93E-04 1.00E+00 Age   
-2.03E-02 2.05E-01 1.00E+00 204305_at NM_005932 MIPEP -2.03E-02 2.36E-01 1.00E+00 202747_s_at NM_004867 ITM2A
-2.01E-02 6.29E-02 1.00E+00 207332_s_at NM_003234 TFRC -1.99E-02 1.75E-01 1.00E+00 200606_at NM_004415 DSP
-1.92E-02 5.61E-02 1.00E+00 202746_at AL021786 ITM2A -1.96E-02 2.05E-01 1.00E+00 204305_at NM_005932 MIPEP
-1.86E-02 2.60E-02 1.00E+00 220576_at NM_024989 PGAP1 -1.91E-02 6.29E-02 1.00E+00 207332_s_at NM_003234 TFRC
1.79E-02 1.69E-01 1.00E+00 209619_at K01144 CD74 -1.82E-02 5.61E-02 1.00E+00 202746_at AL021786 ITM2A
1.77E-02 1.23E-01 1.00E+00 220954_s_at NM_013440 PILRB -1.78E-02 2.60E-02 1.00E+00 220576_at NM_024989 PGAP1
-1.75E-02 1.35E-03 1.00E+00 201865_x_at AI432196 NR3C1 1.76E-02 1.23E-01 1.00E+00 220954_s_at NM_013440 PILRB
-1.73E-02 9.17E-02 1.00E+00 209735_at AF098951 ABCG2 1.69E-02 1.69E-01 1.00E+00 209619_at K01144 CD74
-1.71E-02 2.97E-01 1.00E+00 209314_s_at AK024258 HBS1L 1.68E-02 8.54E-02 1.00E+00 Drug use   
-1.71E-02 5.99E-02 1.00E+00 209267_s_at AB040120 SLC39A8 -1.66E-02 1.35E-03 1.00E+00 201865_x_at AI432196 NR3C1
-1.70E-02 2.88E-01 1.00E+00 218051_s_at NM_022908 NT5DC2 -1.65E-02 9.17E-02 1.00E+00 209735_at AF098951 ABCG2
-1.66E-02 1.83E-01 1.00E+00 213791_at NM_006211 PENK -1.62E-02 5.99E-02 1.00E+00 209267_s_at AB040120 SLC39A8
-1.66E-02 1.75E-01 1.00E+00 203697_at U91903 FRZB -1.61E-02 1.75E-01 1.00E+00 203697_at U91903 FRZB
-1.63E-02 9.02E-02 1.00E+00 202688_at NM_003810 TNFSF10 -1.61E-02 2.88E-01 1.00E+00 218051_s_at NM_022908 NT5DC2
-1.62E-02 2.61E-01 1.00E+00 217757_at NM_000014 A2M -1.55E-02 1.83E-01 1.00E+00 213791_at NM_006211 PENK
-1.60E-02 6.61E-03 1.00E+00 211671_s_at U01351 NR3C1 -1.55E-02 3.39E-01 1.00E+00 222274_at AW975050 FLJ31568